<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-five patients with relapsed or refractory non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were treated by combination chemotherapy with irinotecan <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> (<z:chebi fb="9" ids="27656">CPT</z:chebi>-11) and adriamycin (ADM): <z:chebi fb="9" ids="27656">CPT</z:chebi>-11, 25 mg/m2 on days 1 and 2; ADM, 40 mg/m2 on day 3 </plain></SENT>
<SENT sid="1" pm="."><plain>Nine (36%) of twenty-five patients achieved CR </plain></SENT>
<SENT sid="2" pm="."><plain>Fairly good responses were seen in relapsed B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (4 of 8 in diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and 2 of 2 in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> grade 1), and substantial responses in T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (1 of 4 in peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and 2 of 7 in adult T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001882'>Leukopenia</z:hpo> was frequent but tolerable, and <z:hpo ids='HP_0002014'>diarrhea</z:hpo> minimal </plain></SENT>
<SENT sid="4" pm="."><plain>Combination chemotherapy with a reduced dose <z:chebi fb="9" ids="27656">CPT</z:chebi>-11 and ADM was useful in the treatment of relapsed non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>